Results 151 to 160 of about 402,235 (309)

Effect of a Fermented Milk CombiningLactobacillus AcidophilusCL1285 andLactobacillus Caseiin the Prevention of Antibiotic-Associated Diarrhea: A Randomized, Double-Blind, Placebo-Controlled Trial [PDF]

, 2007
Mélanie Beausoleil, Nadia Fortier, Stéphanie Guénette, Amélie L’Ecuyer, Michel Savoie, Martin Franco, Jean Lachaîne, Karl Weiss   +7 more
openalex   +1 more source

Case‐Based Immunology: B Cells and Systemic Sclerosis Interstitial Lung Disease

Arthritis &Rheumatology, EarlyView.
Interstitial lung disease (ILD) is an important complication of systemic sclerosis (SSc), with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to US Food and Drug Administration–approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of ILDs of other systemic autoimmune
Nina Goldman, Voon Ong, Christopher P. Denton   +2 more
wiley   +1 more source

The Placebo Effect of Insider Dealing Regulation. [PDF]

Oxf J Leg Stud
Enriques L, Alex Lee YH, Romano A.
europepmc   +1 more source

No Placebo Effect beyond Regression to the Mean on the Six Minute Walk Test in Pulmonary Arterial Hypertension Trials. [PDF]

Int J Mol Sci, 2023
Anheyer D, Bugaj TJ, Lüdtke R, Appelbaum S, Trübel H, Ostermann T.   +5 more
europepmc   +1 more source

Improving Effect of Acetic Acid Bacteria (<i>Gluconacetobacter hansenii</i> GK-1) on sIgA and Physical Conditions in Healthy People: Double-Blinded Placebo-Controlled Study

, 2022
Soyogu Yamashita, Mariko Oe, Mamoru Kimura, Yohei OKUYAMA, Satoshi Seino, Daichi Kajiyama, Ryosuke Matsuoka, Yasunobu Masuda, Keiichi Tsukinoki   +8 more
openalex   +2 more sources

Association of Abatacept With Lower Mortality Risk Compared to Rituximab in Rheumatoid Arthritis–Associated Interstitial Lung Disease: An Emulated Target Trial

Arthritis &Rheumatology, EarlyView.
Objective The optimal treatment strategy for rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) remains uncertain, and direct comparative data between biologics are limited. This study aimed to evaluate the effectiveness and safety of abatacept compared with rituximab in patients with RA‐ILD.
Po‐Cheng Shih, Shiow‐Ing Wang, Qing‐Wen Wang, James Cheng Chung Wei   +3 more
wiley   +1 more source

Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-controlled Device Trials: Insights from REDUCE LAP-HF II. [PDF]

Circ Popul Health Outcomes
Girard AA, Mylavarapu U, Komtebedde J, Arnold SV, Solomon SD, Leon MB, Van Veldhuisen DJ, Cutlip DE, Cikes M, Zile MR, Gustafsson F, Lilly SM, Boyle A, Cleland JGF, Kaye DM, Emani S, Gupta DK, Hoendermis ES, Flaherty JD, Muller DW, Kapadia SR, Herrmann HC, Cohen DJ, Shah SJ, Spertus JA.   +24 more
europepmc   +1 more source

Influence of placebo effect in mental disorders research: A systematic review and meta-analysis. [PDF]

Eur J Clin Invest, 2022
Fernández-López R, Riquelme-Gallego B, Bueno-Cavanillas A, Khan KS.   +3 more
europepmc   +1 more source

A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis

Arthritis &Rheumatology, Accepted Article.
Background Individuals with serum elevations of anti‐cyclic citrullinated peptide (anti‐CCP) antibodies are at increased risk for future rheumatoid arthritis (RA). No pharmacologic interventions have been approved for the prevention of RA in such ‘at‐risk’ individuals. However, hydroxychloroquine (HCQ) is used without supporting clinical trial evidence.
Kevin D. Deane, Christopher C. Striebich, Marie L. Feser, James R. O'Dell, Judith A. James, Jeffrey A. Sparks, John M. Davis, Jonathan Graf, Maureen A. McMahon, Elizabeth B. Solow, Lindsy Forbess, Athan Tiliakos, Elena Schiopu, Maria I. Danila, Diane L. Horowitz, Jonathan Kay, Colin D. Strickland, Joel M. Guthridge, Cristina Arriens, Jennifer M. Grossman, M. Kristen Demoruelle, Elizabeth A. Bemis, Ashley Frazer‐Abel, Chelsie L. Fleischer, David A. Fox, Ted R. Mikuls, Melissa Greenleaf, Kate York, Sarah Walker, Lynette Keyes‐Elstein, Margie Byron, Janel Fedler, Ellen A. Goldmuntz, V. Michael Holers   +33 more
wiley   +1 more source

Motor placebo effect in obesity: how ergogenic aids can decrease fatigue and improve motor performance. [PDF]

Eat Weight Disord
Volpino V, Navarra ME, Scarpina F, Piedimonte A, Scacchi M, Bianchi L, Mauro A, Carlino E.   +7 more
europepmc   +1 more source